235 related articles for article (PubMed ID: 30045670)
1. Recognition of cancer mutations in histone H3K36 by epigenetic writers and readers.
Klein BJ; Krajewski K; Restrepo S; Lewis PW; Strahl BD; Kutateladze TG
Epigenetics; 2018; 13(7):683-692. PubMed ID: 30045670
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis for the role of oncogenic histone mutations in modulating H3K36 methylation.
Zhang Y; Shan CM; Wang J; Bao K; Tong L; Jia S
Sci Rep; 2017 Mar; 7():43906. PubMed ID: 28256625
[TBL] [Abstract][Full Text] [Related]
3. Methylation of histone H3 lysine 36 is a barrier for therapeutic interventions of head and neck squamous cell carcinoma.
Caeiro LD; Nakata Y; Borges RL; Zha M; Garcia-Martinez L; Bañuelos CP; Stransky S; Liu T; Chan HL; Brabson J; Domínguez D; Zhang Y; Lewis PW; Aznar Benitah S; Cimmino L; Bilbao D; Sidoli S; Wang Z; Verdun RE; Morey L
Genes Dev; 2024 Feb; 38(1-2):46-69. PubMed ID: 38286657
[TBL] [Abstract][Full Text] [Related]
4. Depletion of H3K36me2 recapitulates epigenomic and phenotypic changes induced by the H3.3K36M oncohistone mutation.
Rajagopalan KN; Chen X; Weinberg DN; Chen H; Majewski J; Allis CD; Lu C
Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33619101
[TBL] [Abstract][Full Text] [Related]
5. Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape.
Lu C; Jain SU; Hoelper D; Bechet D; Molden RC; Ran L; Murphy D; Venneti S; Hameed M; Pawel BR; Wunder JS; Dickson BC; Lundgren SM; Jani KS; De Jay N; Papillon-Cavanagh S; Andrulis IL; Sawyer SL; Grynspan D; Turcotte RE; Nadaf J; Fahiminiyah S; Muir TW; Majewski J; Thompson CB; Chi P; Garcia BA; Allis CD; Jabado N; Lewis PW
Science; 2016 May; 352(6287):844-9. PubMed ID: 27174990
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional specificity of H3K36 methylation.
Lam UTF; Tan BKY; Poh JJX; Chen ES
Epigenetics Chromatin; 2022 May; 15(1):17. PubMed ID: 35581654
[TBL] [Abstract][Full Text] [Related]
7. Understanding histone H3 lysine 36 methylation and its deregulation in disease.
Li J; Ahn JH; Wang GG
Cell Mol Life Sci; 2019 Aug; 76(15):2899-2916. PubMed ID: 31147750
[TBL] [Abstract][Full Text] [Related]
8. Methylation of histone H3 lysine 36 is a barrier for therapeutic interventions of head and neck squamous cell carcinoma.
Caeiro LD; Nakata Y; Borges RL; Garcia-Martinez L; Bañuelos CP; Stransky S; Chan HL; Brabson J; Domínguez D; Zhang Y; Lewis PW; Aznar-Benitah S; Cimmino L; Bilbao D; Sidoli S; Verdun RE; Morey L
bioRxiv; 2023 Nov; ():. PubMed ID: 38076924
[TBL] [Abstract][Full Text] [Related]
9. Histone H3K27M Mutation in Brain Tumors.
El-Hashash AHK
Adv Exp Med Biol; 2021; 1283():43-52. PubMed ID: 33155136
[TBL] [Abstract][Full Text] [Related]
10. Histone H3 Mutations in Cancer.
Wan YCE; Liu J; Chan KM
Curr Pharmacol Rep; 2018; 4(4):292-300. PubMed ID: 30101054
[TBL] [Abstract][Full Text] [Related]
11. Shaping the cellular landscape with Set2/SETD2 methylation.
McDaniel SL; Strahl BD
Cell Mol Life Sci; 2017 Sep; 74(18):3317-3334. PubMed ID: 28386724
[TBL] [Abstract][Full Text] [Related]
12. Histone H3K36 methylation regulates pre-mRNA splicing in Saccharomyces cerevisiae.
Sorenson MR; Jha DK; Ucles SA; Flood DM; Strahl BD; Stevens SW; Kress TL
RNA Biol; 2016; 13(4):412-26. PubMed ID: 26821844
[TBL] [Abstract][Full Text] [Related]
13. Histone 3 lysine 36 to methionine mutations stably interact with and sequester SDG8 in Arabidopsis thaliana.
Lin G; Zhou Y; Li M; Fang Y
Sci China Life Sci; 2018 Feb; 61(2):225-234. PubMed ID: 28975546
[TBL] [Abstract][Full Text] [Related]
14. Histone gene replacement reveals a post-transcriptional role for H3K36 in maintaining metazoan transcriptome fidelity.
Meers MP; Henriques T; Lavender CA; McKay DJ; Strahl BD; Duronio RJ; Adelman K; Matera AG
Elife; 2017 Mar; 6():. PubMed ID: 28346137
[TBL] [Abstract][Full Text] [Related]
15. Unique and Shared Roles for Histone H3K36 Methylation States in Transcription Regulation Functions.
DiFiore JV; Ptacek TS; Wang Y; Li B; Simon JM; Strahl BD
Cell Rep; 2020 Jun; 31(10):107751. PubMed ID: 32521276
[TBL] [Abstract][Full Text] [Related]
16. Histone Lysine-to-Methionine Mutation as Anticancer Drug Target.
Yang J; Qiu Q; Chen L
Adv Exp Med Biol; 2021; 1283():85-96. PubMed ID: 33155140
[TBL] [Abstract][Full Text] [Related]
17. H3K27M in Gliomas Causes a One-Step Decrease in H3K27 Methylation and Reduced Spreading within the Constraints of H3K36 Methylation.
Harutyunyan AS; Chen H; Lu T; Horth C; Nikbakht H; Krug B; Russo C; Bareke E; Marchione DM; Coradin M; Garcia BA; Jabado N; Majewski J
Cell Rep; 2020 Nov; 33(7):108390. PubMed ID: 33207202
[TBL] [Abstract][Full Text] [Related]
18. Combinatorial Genetic Control of Rpd3S Through Histone H3K4 and H3K36 Methylation in Budding Yeast.
Lee KY; Ranger M; Meneghini MD
G3 (Bethesda); 2018 Nov; 8(11):3411-3420. PubMed ID: 30158320
[TBL] [Abstract][Full Text] [Related]
19. Rpp29 regulates histone H3.3 chromatin assembly through transcriptional mechanisms.
Shastrula PK; Lund PJ; Garcia BA; Janicki SM
J Biol Chem; 2018 Aug; 293(32):12360-12377. PubMed ID: 29921582
[TBL] [Abstract][Full Text] [Related]
20. The expanding landscape of 'oncohistone' mutations in human cancers.
Nacev BA; Feng L; Bagert JD; Lemiesz AE; Gao J; Soshnev AA; Kundra R; Schultz N; Muir TW; Allis CD
Nature; 2019 Mar; 567(7749):473-478. PubMed ID: 30894748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
